Clinical Trials
3
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
- Conditions
- Glioblastoma Multiforme
- First Posted Date
- 2015-09-10
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Precision Life Sciences Group
- Target Recruit Count
- 234
- Registration Number
- NCT02546102
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Dignity Health - St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
🇺🇸City of Hope Cancer Center, Duarte, California, United States
A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma
- Conditions
- Glioblastoma Multiforme
- First Posted Date
- 2014-01-30
- Last Posted Date
- 2018-08-13
- Lead Sponsor
- Precision Life Sciences Group
- Target Recruit Count
- 20
- Registration Number
- NCT02049489
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸UC San Diego Moores Cancer Center, La Jolla, California, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
- Conditions
- Glioblastoma Multiforme
- First Posted Date
- 2011-01-20
- Last Posted Date
- 2017-03-20
- Lead Sponsor
- Precision Life Sciences Group
- Target Recruit Count
- 124
- Registration Number
- NCT01280552
- Locations
- 🇺🇸
University of Alabama at Birbingham School of Medicine, South Birmingham, Alabama, United States
🇺🇸Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸UC San Diego Moores Cancer Center, La Jolla, California, United States